1. Ten Common Questions (and Their Answers) About Off-label Drug Use
2. US Food and Drug Administration. “Off‐label” and investigational use of marketed drugs biologics and medical devices. Guidance for institutional review boards and clinical investigators.https://www.fda.gov/regulatory-information/search-fda-guidance-documents/label-and-investigational-use-marketed-drugs-biologics-and-medical-devices. Published January 1998. Accessed July 27 2021.
3. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
4. KETALAR (ketamine hydrochloride) drug label.https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/016812Orig1s046lbl.pdf. Published2020. Accessed July 27 2021.
5. Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans